UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 93

Sortiert nach

Editorial: getting bullish about portal hypertension—chronic treatment with oral taurine? Author's reply

Alimentary pharmacology & therapeutics, 2018-02, Vol.47 (4), p.534-535

Ferlitsch, A.

2018

Link zum Volltext

Verfügbarkeit prüfen

Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (7), p.980-988

2018

Link zum Volltext

Verfügbarkeit prüfen

Editorial: optimal dose of carvedilol in portal hypertension…nearly there. Authors' reply

Alimentary pharmacology & therapeutics, 2018-05, Vol.47 (9), p.1329-1330

2018

Link zum Volltext

Verfügbarkeit prüfen

Randomised clinical study: the effects of oral taurine 6g/day vs placebo on portal hypertension

Alimentary pharmacology & therapeutics, 2018-01, Vol.47 (1), p.86-94

2018

Link zum Volltext

Verfügbarkeit prüfen

Interferon‐free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease

Alimentary pharmacology & therapeutics, 2017-01, Vol.45 (1), p.139-149

2017

Link zum Volltext

Verfügbarkeit prüfen

Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose‐response study

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (8), p.1162-1169

2018

Link zum Volltext

Verfügbarkeit prüfen

Editorial: von Willebrand factor and CRP levels may predict survival in liver cirrhosis—Authors’ reply

Alimentary pharmacology & therapeutics, 2018-06, Vol.47 (11), p.1537-1538

2018

Link zum Volltext

Verfügbarkeit prüfen

Impact of patatin‐like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension

Alimentary pharmacology & therapeutics, 2018-08, Vol.48 (4), p.451-459

2018

Link zum Volltext

Verfügbarkeit prüfen

The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma - a pilot study

Alimentary pharmacology & therapeutics, 2012-01, Vol.35 (1), p.83-91

2012

Link zum Volltext

Verfügbarkeit prüfen

Interferon‐free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responses

Alimentary pharmacology & therapeutics, 2015-09, Vol.42 (6), p.707-718

2015

Link zum Volltext

Verfügbarkeit prüfen

Impact of high-volume, intermediate-volume and low-volume bowel preparation on colonoscopy quality and patient satisfaction: An observational study

United European gastroenterology journal, 2019-02, Vol.7 (1), p.114-124

2019

Link zum Volltext

Verfügbarkeit prüfen

Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (7), p.966-979

2018

Link zum Volltext

Verfügbarkeit prüfen

HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension

Journal of viral hepatitis, 2010-06, Vol.17 (6), p.400-409

2010

Link zum Volltext

Verfügbarkeit prüfen

Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt

Gut, 2003-06, Vol.52 (6), p.879-885

2003

Link zum Volltext

Verfügbarkeit prüfen

Erythropoietin increases platelet reactivity and platelet counts in patients with alcoholic liver cirrhosis: a randomized, double‐blind, placebo‐controlled study

Alimentary pharmacology & therapeutics, 2004-08, Vol.20 (4), p.437-443

2004

Link zum Volltext

Verfügbarkeit prüfen

Short‐ and long‐term effects of therapy with interferon‐α and pegylated interferon‐α/ribavirin on platelet plug formation and von Willebrand factor release in patients with chronic hepatitis C

Alimentary pharmacology & therapeutics, 2005-01, Vol.21 (1), p.49-55

2005

Link zum Volltext

Verfügbarkeit prüfen

Bradycardia and sinus arrest during percutaneous ethanol injection therapy for hepatocellular carcinoma

European journal of clinical investigation, 2004-03, Vol.34 (3), p.218-223

2004

Link zum Volltext

Verfügbarkeit prüfen

Impact of liver resection on portal venous pressure and renal function

Critical care (London, England), 2013-03, Vol.17 (S2), p.P404-P404, Article P404

2013

Link zum Volltext

Verfügbarkeit prüfen

Letter: sorafenib in portal hypertension - authors' reply

Alimentary pharmacology & therapeutics, 2012-11, Vol.36 (10), p.994-995

2012

Link zum Volltext

Verfügbarkeit prüfen

A Prospective Evaluation of Pulmonary, Systemic and Hepatic Haemodynamics in HIV–HCV-Coinfected Patients before and after Antiviral Therapy with Pegylated Interferon and Ribavirin

Antiviral therapy, 2012-01, Vol.17 (7), p.1327-1334

2012

Link zum Volltext

Verfügbarkeit prüfen

von Willebrand factor antigen: a novel on-treatment predictor of response to antiviral therapy in chronic hepatitis C genotypes 1 and 4

Antiviral therapy, 2010-01, Vol.15 (6), p.831-839

2010

Link zum Volltext

Verfügbarkeit prüfen

HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension: Fibrosis progression and portal hypertension in HIV-HCV co-infection

Journal of viral hepatitis, 2010-06, Vol.17 (6), p.400-409

2010

Link zum Volltext

Verfügbarkeit prüfen

Short- and long-term effects of therapy with interferon-a and pegylated interferon-α/ribavirin on platelet plug formation and von Willebrand factor release in patients with chronic hepatitis C

Alimentary pharmacology & therapeutics, 2005, Vol.21 (1), p.49-55

2005

Link zum Volltext

Verfügbarkeit prüfen

Standardized ergometer exercise in trained rowers: effect on reversible platelet microaggregates and platelet aggregation

VASA, 1981, Vol.10 (1), p.4

1981

Link zum Volltext

Verfügbarkeit prüfen

Dermatologlyphic investigations in a kindred manifesting familial atrial septal defect (ostium secundum). A contribution to the problem of genetic counselling in multifactorial inheritance (author's transl)

Wiener Klinische Wochenschrift, 1975-02, Vol.87 (3), p.99-101

1975

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 93

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

SpracheKoreanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(72)

Publikationsform

Artikel
(93)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Editorial: getting bullish about portal hypertension—chronic treatment with oral taurine? Author's reply

Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity

Editorial: optimal dose of carvedilol in portal hypertension…nearly there. Authors' reply

Randomised clinical study: the effects of oral taurine 6g/day vs placebo on portal hypertension

Interferon‐free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease

Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose‐response study

Editorial: von Willebrand factor and CRP levels may predict survival in liver cirrhosis—Authors’ reply

Impact of patatin‐like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension

The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma - a pilot study

Interferon‐free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responses

Impact of high-volume, intermediate-volume and low-volume bowel preparation on colonoscopy quality and patient satisfaction: An observational study

Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding

HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension

Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt

Erythropoietin increases platelet reactivity and platelet counts in patients with alcoholic liver cirrhosis: a randomized, double‐blind, placebo‐controlled study

Short‐ and long‐term effects of therapy with interferon‐α and pegylated interferon‐α/ribavirin on platelet plug formation and von Willebrand factor release in patients with chronic hepatitis C

Bradycardia and sinus arrest during percutaneous ethanol injection therapy for hepatocellular carcinoma

Impact of liver resection on portal venous pressure and renal function

Letter: sorafenib in portal hypertension - authors' reply

A Prospective Evaluation of Pulmonary, Systemic and Hepatic Haemodynamics in HIV–HCV-Coinfected Patients before and after Antiviral Therapy with Pegylated Interferon and Ribavirin

von Willebrand factor antigen: a novel on-treatment predictor of response to antiviral therapy in chronic hepatitis C genotypes 1 and 4

HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension: Fibrosis progression and portal hypertension in HIV-HCV co-infection

Short- and long-term effects of therapy with interferon-a and pegylated interferon-α/ribavirin on platelet plug formation and von Willebrand factor release in patients with chronic hepatitis C

Standardized ergometer exercise in trained rowers: effect on reversible platelet microaggregates and platelet aggregation

Dermatologlyphic investigations in a kindred manifesting familial atrial septal defect (ostium secundum). A contribution to the problem of genetic counselling in multifactorial inheritance (author's transl)

Aktive Filter

Suchergebnisse filtern